Announcement of TTY Biopharm's unaudited income information in April 2021
2021.5.13
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/05/13 | Time of announcement | 17:26:28 |
| Subject | Announcement of TTY Biopharm's unaudited income information in April 2021 | ||||
| Date of events | 2021/05/13 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/05/13 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $353,723 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $88,509 thousands, and a consolidated income before tax of $89,709 thousands in April 2021; net income attributed to stockholders of the company was $70,503 thousands; EPS is $0.28. Year-to-date consolidated net sales was $1,317,779 thousands (in NT dollars; unaudited), a consolidated operating profit was $307,671 thousands and consolidated income before tax was $342,753 thousands until April 2021; year-to-date net income attributed to stockholders of the company was $273,646 thousands; EPS is $1.10. 6.Countermeasures:N/A 7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||